JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$4.76B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.21B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$3.81B |
| 4 |
Apple
AAPL
|
+$3.39B |
| 5 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$3.1B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.48B |
| 2 |
S&P Global
SPGI
|
+$2.45B |
| 3 |
Coca-Cola
KO
|
+$1.73B |
| 4 |
Adobe
ADBE
|
+$1.59B |
| 5 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$1.3B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.97% |
| 2 | Technology | 21.69% |
| 3 | Healthcare | 9.58% |
| 4 | Consumer Discretionary | 9.07% |
| 5 | Financials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5151
Similarweb
SMWB
$709M
| $195K | ﹤0.01% |
21,661
+19,792
| +1,059% | +$146K |
2021 Q2
11 quarters
|
|
5152
Bank7 Corp
BSVN
$530M
| $195K | ﹤0.01% |
6,913
+3,797
| +122% | +$102K |
2018 Q4
21 quarters
|
|
5153
KVH Industries
KVHI
$124M
| $194K | ﹤0.01% |
38,042
-4,254
| -10% | -$20.9K |
2023 Q2
3 quarters
|
|
5154
Oportun Financial
OPRT
$383M
| $194K | ﹤0.01% |
79,664
+55,977
| +236% | +$202K |
2019 Q3
18 quarters
|
|
|
AFCG
5155
AFC Gamma
AFCG
$73.7M
| $193K | ﹤0.01% |
22,816
-17,981
| -44% | -$146K |
2021 Q2
11 quarters
|
|
5156
ENI
E
$78.2B
| $193K | ﹤0.01% |
6,095
-36,988
| -86% | -$1.17M |
2013 Q2
43 quarters
|
|
|
RFI
5157
Cohen & Steers Total Return Realty Fund
RFI
$280M
| $193K | ﹤0.01% |
16,250
| – | – |
2023 Q3
2 quarters
|
|
5158
Nuveen Churchill Direct Lending
NCDL
$538M
| $193K | ﹤0.01% |
+10,692
| New | +$186K |
2024 Q1
0 quarters
|
|
5159
Innovator Power Buffer Step-Up Strategy ETF
PSTP
$134M
| $193K | ﹤0.01% |
6,539
+5,398
| +473% | +$156K |
2023 Q3
2 quarters
|
|
|
GPGI
5160
GPGI Inc
GPGI
$3.82B
| $193K | ﹤0.01% |
32,065
+19,233
| +150% | +$86.7K |
2022 Q1
8 quarters
|
|
5161
Sonida Senior Living
SNDA
$1.78B
| $193K | ﹤0.01% |
6,738
+6,699
| +17,177% | +$100K |
2023 Q3
2 quarters
|
|
5162
CALL
Novanta
NOVT
$5.64B
| $192K | ﹤0.01% |
+1,100
| New | +$180K |
2024 Q1
0 quarters
|
|
5163
Hooker Furnishings Corp
HOFT
$138M
| $192K | ﹤0.01% |
7,994
+890
| +13% | +$21.3K |
2016 Q3
30 quarters
|
|
5164
Anterix
ATEX
$1.64B
| $191K | ﹤0.01% |
5,697
-2,858
| -33% | -$96.1K |
2017 Q4
25 quarters
|
|
5165
PUT
Vaxcyte
PCVX
$9.93B
| $191K | ﹤0.01% |
+2,800
| New | +$194K |
2024 Q1
0 quarters
|
|
5166
Aura Biosciences
AURA
$640M
| $191K | ﹤0.01% |
24,285
+5,925
| +32% | +$49.1K |
2021 Q4
9 quarters
|
|
5167
James Hardie Industries
JHX
$14.8B
| $190K | ﹤0.01% |
4,708
-23,121
| -83% | -$889K |
2015 Q1
36 quarters
|
|
5168
Bally's
BALY
$707M
| $190K | ﹤0.01% |
13,633
-5,883
| -30% | -$68.5K |
2019 Q2
19 quarters
|
|
5169
PUT
Packaging Corp of America
PKG
$20.5B
| $190K | ﹤0.01% |
+1,000
| New | +$173K |
2024 Q1
0 quarters
|
|
5170
Invesco KBW High Dividend Yield Financial ETF
KBWD
$357M
| $189K | ﹤0.01% |
12,205
-29,526
| -71% | -$452K |
2020 Q1
16 quarters
|
|
5171
Crescent Capital BDC
CCAP
$334M
| $188K | ﹤0.01% |
10,921
-6,332
| -37% | -$106K |
2023 Q3
2 quarters
|
|
|
CRGX
5172
DELISTED
CARGO Therapeutics
CRGX
| $188K | ﹤0.01% |
+8,438
| New | +$201K |
2024 Q1
0 quarters
|
|
5173
Nautilus Biotechnolgy
NAUT
$225M
| $188K | ﹤0.01% |
64,001
+3,403
| +6% | +$9.65K |
2021 Q4
9 quarters
|
|
5174
PUT
Harmony Biosciences
HRMY
$2.29B
| $188K | ﹤0.01% |
+5,600
| New | +$180K |
2024 Q1
0 quarters
|
|
5175
PUT
Shell
SHEL
$278B
| $188K | ﹤0.01% |
+2,800
| New | +$179K |
2024 Q1
0 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2024 Portfolio in Review
As of Q1 2024, JP Morgan Chase held 8,132 positions worth $1.18T, up 14% from $1.04T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
JP Morgan Chase deployed $48.7B of net new capital in Q1 2024, opening 625 new positions and adding to 3,255 existing holdings. Its largest new stake was Flutter Entertainment: 1,314,201 shares worth $260M.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Vanguard Total International Bond ETF, an estimated $2.48B trimmed.
- JP Morgan Chase's largest Q1 2024 buy was Flutter Entertainment: 1,314,201 shares worth $260M.
- JP Morgan Chase added most to Vanguard S&P 500 ETF in Q1 2024, an estimated $4.76B increase.
- JP Morgan Chase's biggest Q1 2024 reduction was Vanguard Total International Bond ETF, cutting an estimated $2.48B.
- JP Morgan Chase fully exited BlackRock Flexible Income ETF in Q1 2024, selling an estimated $139M.
- JP Morgan Chase's ten largest holdings make up 21% of its $1.18T portfolio in Q1 2024.
- JP Morgan Chase opened 625 new positions and closed 764 in Q1 2024.
- JP Morgan Chase's portfolio value rose 14% quarter-over-quarter to $1.18T.
Based on JP Morgan Chase's 13F filing for Q1 2024, filed 10 May 2024.